ivim tirzepatide shortage FDA confirms is still over, gives compounders a grace period Hims vs Henry Meds vs

When you don't have enough inventory, output stops, and when you have too much inventory, cash gets stuck

Chi H, Chang H-Y, Sang T-K

Any hair-shedding reports should be considered in that broader context

Overall, about one in five (22%) adults who are not currently taking GLP-1 drugs (88% of the public) say they would be interested in taking a GLP-1 drug to lose weight, including just 7% who say they would be very interested. This rises to four in ten (43%) among adults who are not currently taking a GLP-1 but report being diagnosed as overweight or obese in the past five years, and about one in four (27%) among those who say they have been diagnosed with diabetes or heart disease